The Heifets Laboratory
Welcome to the Heifets Lab
Our research group is dedicated to understanding and improving on powerful, rapid-acting therapies for psychiatric disease, such as ketamine, MDMA and psilocybin. We bridge basic science and clinical trials, connecting neuroscience, psychiatry and anesthesiology in pursuit of highly effective, safe treatment strategies scalable to the millions of patients who need them.
Follow Us on Twitter
I'm looking for a post-bac research assistant to help run our studies on the impact of psychedelics on memory! Preferably with an interest in cognitive neuroscience (not just psychedelics or clinical research) and knowledge of coding/data analysis.
https://utaustin.wd1.myworkdayjobs.com/UTstaff/job/UT-MAIN-CAMPUS/Research-Associate-I_R_00045822
Imagine being in a magic mushroom study, and you get the placebo. Womp womp. This leads to what researchers are now calling the "knowcebo" effect. This wipes out the impact of placebo controls in these studies. @psybalazs :
Balazs Szigeti: Unblinding Effects in Psychedelic Research
Podcast Episode · CogNation · April 25 · 55m
podcasts.apple.com
So grateful for the honor of becoming an #NASmember! #NAS163
I had the honor of a lifetime this evening by being inducted into the National Academy of Sciences. I want to thank the many PhD students and postdocs in my lab over the past almost 40 years whose hard, creative, and impactful work made this possible. @SinaiBrain @IcahnMountSinai
Mechanism-guided identification of antidepressant G protein-coupled receptor drug targets: Cell
Mechanism-guided identification of antidepressant G protein-coupled receptor drug targets
Uncovering ketamine’s rapid antidepressant effects via somatostatin-expressing interneurons in the prefrontal cortex enables...
www.cell.com
Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails
Psychedelics in Psychiatry
This Viewpoint offers perspectives on how the psychedelic research renaissance can stay on the path that leads to ...
jamanetwork.com
America is in the middle of a mental health crisis.
Half of all Americans will experience a mental or behavioral health condition, with even higher rates among veterans.
Yet medical professionals still lack the objective tools needed to determine what treatments work and for
@TheBorisLab Larger sample sizes. More psychedelically naive patients. More long term follow up. More complete and honest reporting of adverse effects. More careful blinding. More transparent consent and more research on whether patients think the consent was true and useful when viewed after
Dead on. Step 1 to understanding what Ibogaine and psychedelics can do is easing regs and promoting science. I hope the same enthusiasm extends to creating and sustaining the social and psychological supports needed to “scale”
The contradiction at the heart of Republicans’ embrace of psychedelics
Without additional resources, psychedelics like ibogaine can’t support recovery, mental health
https://www.statnews.com/2026/04/20/trump-executive-order-psychedelics-republicans-veterans-ibogaine/
Real world studies, long term studies in the VA system, better reimbursement for interlocked therapy / coaching / medical care and intense interventions like, perhaps, psychedelic treatment, creative exploration of what kind of things we can do on-drug to engage the incredible